Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileJoseph T. Coyle, M.D.

TitleEben S. Draper Professor of Psychiatry
InstitutionMcLean Hospital
DepartmentPsychiatry
AddressMclean Hospital
Mailman Research Center
115 Mill St
Belmont MA 02478
Phone617/855-2101
Fax617/855-2705
vCardDownload vCard (login for email)

Collapse Biography 
Collapse awards and honors
1968Henry Strong Denison Research Scholarship
1969Alpha Omega Alpha Student Research Award
1978A.E.Bennett Award in Basic Science
1979John Jacob Abel Award
1979Sato International Memorial Award
1982Daniel Efron Award
1985Foundations' Fund Prize for Research in Psychiatry
1986Alpha Omega Alpha Honor Society
1990Institute of Medicine of the National Academy of Sciences
1990Nancy and Daniel Weisman Award for Research on Mental Retardation
1991Edward A. Strecker Award
1991Gold Medal Award
1991 - 1992President
1992William R. McAlpin, Jr. Research Achievement Award
1994Fellow
1997Award for Neuropsychiatric Research
1997Exemplary Psychiatrist Award
2001 - 2002 President
20012001 Highly Cited Researchers Award
2001 - 2004Council
2001Special Achievement Award
2004Lieber Prize for Schizophrenia Research
2006Fellow
20072007 Sanctae Crucis Award
20072008 Julius Axelrod Award

Collapse Overview 
Collapse overview
Joseph T. Coyle, M.D. holds the Eben S. Draper Chair of Psychiatry and Neuroscience at Harvard Medical School. From 1991 to 2001, he served as Chairman of the Consolidated Department of Psychiatry at Harvard Medical School, which included the nine hospital programs of psychiatry affiliated with the Medical School. After graduating from Holy Cross College, he received his medical degree (M.D.) from Johns Hopkins School of Medicine in 1969. Following an internship in Pediatrics, he spent three years at the National Institutes of Health as a research fellow in the laboratory of Nobel laureate Julius Axelrod, Ph.D. He returned to Hopkins in 1973 to complete his Psychiatric residency, in which he is board certified, and joined the faculty in 1975. In 1980, he was promoted to Professor of Neuroscience, Pharmacology and Psychiatry; and in 1982 he assumed the Directorship of the Division of Child and Adolescent Psychiatry, being named the Distinguished Service Professor in 1985.

Dr. Coyle's research interests include developmental neurobiology, mechanisms of neuronal vulnerability and psychopharmacology. In particular, he has carried out research on the role of glutamatergic neurons in the pathophysiology of neuropsychiatric disorders for 30 years. He has a long commitment to training. In the mid-1980s, he was the PI of a NIMH Training Grant that had a core curriculum, which introduced PhD fellows to psychiatric illnesses with patient demonstrations. While President of the Society of Neuroscience, he worked with NIMH to develop a minority Training Grant. For the last 10 years, he has served as co-PI on this grant, which was the foundation for minority mentoring and net-working for the Society. He has published over 500 scientific articles and has edited seven books. His research has been cited over 35,000 times, and his H-factor is 93. He has received continuous NIH funding for his research for 30 years and is the Director of an NIMH Conte Center on the Neurobiology of Schizophrenia (2001-11).

Dr. Coyle is a member of the Institute of Medicine of the National Academy of Sciences (1990), a fellow of the American Academy of Arts and Sciences (1993), a Distinguished Fellow of the American Psychiatric Association, a fellow of the American College of Psychiatry and fellow of the American Association for the Advancement of Science. He served on the National Advisory Mental Health Council for the National Institute of Mental Health (1990-94). He is Past-President of the American College of Neuropsychopharmacology (2001) and Past-President (1991) of the Society for Neuroscience, an organization with more than 35,000 members. He sits on over 20 journal editorial boards including JAMA and is the Editor-in-Chief of the Archives of General Psychiatry, the most highly cited journal in the field (citation impact:15.98).


Collapse Research 
Collapse research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
R21DA035427     (COYLE, JOSEPH T)May 15, 2013 - Apr 30, 2015
NIH/NIDA
Drug Abuse, Schizophrenia, NMDA Receptor
Role: Principal Investigator

P50MH060450     (COYLE, JOSEPH T)Jul 21, 2000 - May 31, 2012
NIH/NIMH
Glutamatergic Dysfunction and Schizophrenia
Role: Principal Investigator

R01MH051290     (COYLE, JOSEPH T)Aug 1, 1994 - Apr 30, 2018
NIH/NIMH
Psychosis and Brain Glutamate
Role: Principal Investigator

P01MH046529     (MORAN, TIMOTHY H.)Apr 1, 1990 - Mar 31, 1994
NIH/NIMH
GENE DOSAGE EFFECTS ON THE DEVELOPING BRAIN
Role: Co-Principal Investigator

U09MH041623     (COYLE, JAMES T)Sep 30, 1985 - Oct 31, 1989
NIH/NIMH
SCIENTIFIC EVALUATION AND PLANNING
Role: Principal Investigator

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Coyle JT, Konopaske G. Glutamatergic Dysfunction in Schizophrenia Evaluated With Magnetic Resonance Spectroscopy. JAMA Psychiatry. 2016 Jul 1; 73(7):649-50. PMID: 27305626.
    View in: PubMed
  2. Perez EJ, Cepero ML, Perez SU, Coyle JT, Sick TJ, Liebl DJ. EphB3 signaling propagates synaptic dysfunction in the traumatic injured brain. Neurobiol Dis. 2016 Oct; 94:73-84. PMID: 27317833.
    View in: PubMed
  3. Coyle JT. My Life in Clinical Neuroscience: The Beginning. Adv Pharmacol. 2016; 76:1-12. PMID: 27288071.
    View in: PubMed
  4. Kangas BD, Bergman J, Coyle JT. Touchscreen assays of learning, response inhibition, and motivation in the marmoset (Callithrix jacchus). Anim Cogn. 2016 May; 19(3):673-7. PMID: 26846231.
    View in: PubMed
  5. Balu DT, Li Y, Takagi S, Presti KT, Ramikie TS, Rook JM, Jones CK, Lindsley CW, Conn PJ, Bolshakov VY, Coyle JT. An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia. Neuropsychopharmacology. 2016 Jul; 41(8):2052-61. PMID: 26741285.
    View in: PubMed
  6. Konopaske GT, Coyle JT. Possible compensatory mechanisms for glutamatergic disconnection found in the auditory cortex in schizophrenia. Biol Psychiatry. 2015 Jun 1; 77(11):923-4. PMID: 25959563.
    View in: PubMed
  7. Ishiwata S, Umino A, Balu DT, Coyle JT, Nishikawa T. Neuronal serine racemase regulates extracellular D-serine levels in the adult mouse hippocampus. J Neural Transm (Vienna). 2015 Aug; 122(8):1099-103. PMID: 25782690.
    View in: PubMed
  8. Puhl MD, Berg AR, Bechtholt AJ, Coyle JT. Availability of N-Methyl-d-Aspartate Receptor Coagonists Affects Cocaine-Induced Conditioned Place Preference and Locomotor Sensitization: Implications for Comorbid Schizophrenia and Substance Abuse. J Pharmacol Exp Ther. 2015 Jun; 353(3):465-70. PMID: 25788713; PMCID: PMC4429674 [Available on 06/01/16].
  9. Konopaske GT, Subburaju S, Coyle JT, Benes FM. Altered prefrontal cortical MARCKS and PPP1R9A mRNA expression in schizophrenia and bipolar disorder. Schizophr Res. 2015 May; 164(1-3):100-8. PMID: 25757715; PMCID: PMC4409526 [Available on 05/01/16].
  10. Takagi S, Balu DT, Coyle JT. Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice. Schizophr Res. 2015 Mar; 162(1-3):216-21. PMID: 25592804; PMCID: PMC4339465 [Available on 03/01/16].
  11. Balu DT, Coyle JT. The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond. Curr Opin Pharmacol. 2015 Feb; 20:109-15. PMID: 25540902.
    View in: PubMed
  12. Coyle JT. Farewell. JAMA Psychiatry. 2014 Dec 1; 71(12):1321-2. PMID: 25470990.
    View in: PubMed
  13. Konopaske GT, Lange N, Coyle JT, Benes FM. Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder. JAMA Psychiatry. 2014 Dec 1; 71(12):1323-31. PMID: 25271938.
    View in: PubMed
  14. Zhang S, Wang S, Puhl MD, Jiang X, Hyrc KL, Laciny E, Wallendorf MJ, Pappan KL, Coyle JT, Wice BM. Global biochemical profiling identifies ß-hydroxypyruvate as a potential mediator of type 2 diabetes in mice and humans. Diabetes. 2015 Apr; 64(4):1383-94. PMID: 25368100; PMCID: PMC4375086 [Available on 04/01/16].
  15. Puhl MD, Mintzopoulos D, Jensen JE, Gillis TE, Konopaske GT, Kaufman MJ, Coyle JT. In vivo magnetic resonance studies reveal neuroanatomical and neurochemical abnormalities in the serine racemase knockout mouse model of schizophrenia. Neurobiol Dis. 2015 Jan; 73:269-74. PMID: 25461193; PMCID: PMC4408217 [Available on 01/01/16].
  16. Balu DT, Coyle JT. Chronic D-serine reverses arc expression and partially rescues dendritic abnormalities in a mouse model of NMDA receptor hypofunction. Neurochem Int. 2014 Sep; 75:76-8. PMID: 24915645; PMCID: PMC4122302.
  17. Balu DT, Takagi S, Puhl MD, Benneyworth MA, Coyle JT. D-serine and serine racemase are localized to neurons in the adult mouse and human forebrain. Cell Mol Neurobiol. 2014 Apr; 34(3):419-35. PMID: 24436034; PMCID: PMC4505359.
  18. Coyle JT, Ongur D. Relapse in alcohol use disorder--reply. JAMA Psychiatry. 2013 Nov; 70(11):1248. PMID: 24196497.
    View in: PubMed
  19. Coyle JT. Brain structural alterations induced by fetal exposure to cocaine persist into adolescence and affect behavior. JAMA Psychiatry. 2013 Oct; 70(10):1113-4. PMID: 23986322.
    View in: PubMed
  20. Coyle JT. Nitric oxide and symptom reduction in schizophrenia. JAMA Psychiatry. 2013 Jul; 70(7):664-5. PMID: 23699799.
    View in: PubMed
  21. Balu DT, Li Y, Puhl MD, Benneyworth MA, Basu AC, Takagi S, Bolshakov VY, Coyle JT. Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction. Proc Natl Acad Sci U S A. 2013 Jun 25; 110(26):E2400-9. PMID: 23729812; PMCID: PMC3696825.
  22. Konopaske GT, Bolo NR, Basu AC, Renshaw PF, Coyle JT. Time-dependent effects of haloperidol on glutamine and GABA homeostasis and astrocyte activity in the rat brain. Psychopharmacology (Berl). 2013 Nov; 230(1):57-67. PMID: 23660600; PMCID: PMC3797182.
  23. Coyle JT. Much more than a name change. JAMA Psychiatry. 2013 Jan; 70(1):8. PMID: 23303609.
    View in: PubMed
  24. Li Y, Sacchi S, Pollegioni L, Basu AC, Coyle JT, Bolshakov VY. Identity of endogenous NMDAR glycine site agonist in amygdala is determined by synaptic activity level. Nat Commun. 2013; 4:1760. PMID: 23612301; PMCID: PMC3641574.
  25. Coyle JT. NMDA receptor and schizophrenia: a brief history. Schizophr Bull. 2012 Sep; 38(5):920-6. PMID: 22987850; PMCID: PMC3446237.
  26. Bauchner H, Albert DM, Coyle JT, Freischlag JA, Larrabee WF, Levine PA, Redberg RF, Rivara FP, Robinson JK, Rosenberg RN. The JAMA network journals: new names for the archives journals. Arch Intern Med. 2012 Jul 23; 172(14):1056. PMID: 22751685.
    View in: PubMed
  27. Benneyworth MA, Coyle JT. Altered acquisition and extinction of amphetamine-paired context conditioning in genetic mouse models of altered NMDA receptor function. Neuropsychopharmacology. 2012 Oct; 37(11):2496-504. PMID: 22763616; PMCID: PMC3442344.
  28. Bauchner H, Albert DM, Coyle JT, Freischlag JA, Larrabee WF, Levine PA, Redberg RF, Redberg RA, Rivara FP, Robinson JK, Rosenberg RN. The JAMA Network journals: new names for the archives journals. Arch Facial Plast Surg. 2012 Jul-Aug; 14(4):236. PMID: 22751939.
    View in: PubMed
  29. Bauchner H, Albert DM, Coyle JT, Freischlag JA, Larrabee WF, Levine PA, Redberg RA, Rivara FP, Robinson JK, Rosenberg RN. The JAMA Network Journals: new names for the archives journals. Arch Pediatr Adolesc Med. 2012 Jul 1; 166(7):662. PMID: 22751884.
    View in: PubMed
  30. Bauchner H, Albert DM, Coyle JT, Freischlag JA, Larrabee WF, Levine PA, Redberg RA, Rivara FP, Robinson JK, Rosenberg RN. The JAMA Network Journals: New Names for the Archives Journals. Arch Neurol. 2012 Jul 1; 69(7):817. PMID: 22772586.
    View in: PubMed
  31. Coyle JT. Changing to JAMA Psychiatry. Arch Gen Psychiatry. 2012 Jul 1; 69(7):661. PMID: 23117594.
    View in: PubMed
  32. Bauchner H, Albert DM, Coyle JT, Freischlag JA, Larrabee WF, Levine PA, Redberg RF, Rivara FP, Robinson JK, Rosenberg RN. The JAMA Network Journals: New Names for the Archives Journals. Arch Otolaryngol Head Neck Surg. 2012 Jul 1; 138(7):620. PMID: 23753751.
    View in: PubMed
  33. Bauchner H, Albert DM, Coyle JT, Freischlag JA, Larrabee WF, Levine PA, Redberg RF, Rivara FP, Robinson JK, Rosenberg RN. The JAMA Network Journals: New Names for the Archives Journals. Arch Ophthalmol. 2012 Jul; 130(7):914. PMID: 23403910.
    View in: PubMed
  34. Bauchner H, Albert DM, Coyle JT, Freischlag JA, Larrabee WF, Levine PA, Redberg RF, Rivara FP, Robinson JK, Rosenberg RN. The JAMA Network Journals: New Names for the Archives Journals. Arch Gen Psychiatry. 2012 Jul 1; 69(7):660. PMID: 23754012.
    View in: PubMed
  35. Bauchner H, Albert DM, Coyle JT, Freischlag JA, Larrabee WF, Levine PA, Redberg RF, Rivara FP, Robinson JK, Rosenberg RN. The JAMA Network Journals: New Names for the Archives Journals. Arch Neurol. 2012 Jul; 69(7):817. PMID: 23403866.
    View in: PubMed
  36. Coyle JT. Changing to JAMA Psychiatry. Arch Gen Psychiatry. 2012 Jul 1; 69(7):661. PMID: 23754033.
    View in: PubMed
  37. Bauchner H, Albert DM, Coyle JT, Freischlag JA, Larrabee WF, Levine PA, Redberg RA, Rivara FP, Robinson JK, Rosenberg RN. The JAMA Network journals: new names for the archives journals. Arch Surg. 2012 Jul; 147(7):587. PMID: 22802053.
    View in: PubMed
  38. Bauchner H, Albert DM, Coyle JT, Freischlag JA, Larrabee WF, Levine PA, Redberg RF, Redberg RA, Rivara FP, Robinson JK, Rosenberg RN. The JAMA Network Journals: new names for the archives journals. Arch Dermatol. 2012 Jul; 148(7):788. PMID: 22751861.
    View in: PubMed
  39. Schaevitz LR, Picker JD, Rana J, Kolodny NH, Shane B, Berger-Sweeney JE, Coyle JT. Glutamate carboxypeptidase II and folate deficiencies result in reciprocal protection against cognitive and social deficits in mice: implications for neurodevelopmental disorders. Dev Neurobiol. 2012 Jun; 72(6):891-905. PMID: 22076974; PMCID: PMC3401954.
  40. Coyle JT. Changes in JAMA and the Archives of General Psychiatry: what they mean for readers and authors. Arch Gen Psychiatry. 2012 May; 69(5):447-8. PMID: 22566577.
    View in: PubMed
  41. Balu DT, Coyle JT. Neuronal D-serine regulates dendritic architecture in the somatosensory cortex. Neurosci Lett. 2012 May 31; 517(2):77-81. PMID: 22521586; PMCID: PMC3400345.
  42. Benneyworth MA, Li Y, Basu AC, Bolshakov VY, Coyle JT. Cell selective conditional null mutations of serine racemase demonstrate a predominate localization in cortical glutamatergic neurons. Cell Mol Neurobiol. 2012 May; 32(4):613-24. PMID: 22362148.
    View in: PubMed
  43. Chen Y, Norton DJ, McBain R, Gold J, Frazier JA, Coyle JT. Enhanced local processing of dynamic visual information in autism: evidence from speed discrimination. Neuropsychologia. 2012 Apr; 50(5):733-9. PMID: 22261399; PMCID: PMC4094132.
  44. Coyle JT, Basu A, Benneyworth M, Balu D, Konopaske G. Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications. Handb Exp Pharmacol. 2012; (213):267-95. PMID: 23027419.
    View in: PubMed
  45. Sullivan SJ, Esguerra M, Wickham RJ, Romero GE, Coyle JT, Miller RF. Serine racemase deletion abolishes light-evoked NMDA receptor currents in retinal ganglion cells. J Physiol. 2011 Dec 15; 589(Pt 24):5997-6006. PMID: 22041185; PMCID: PMC3286681.
  46. Balu DT, Basu AC, Corradi JP, Cacace AM, Coyle JT. The NMDA receptor co-agonists, D-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex. Neurobiol Dis. 2012 Feb; 45(2):671-82. PMID: 22024716; PMCID: PMC3259183.
  47. Coyle JT. Online first. Arch Gen Psychiatry. 2011 Apr 4; 68(4):339. PMID: 22639041.
    View in: PubMed
  48. Benneyworth MA, Basu AC, Coyle JT. Discordant behavioral effects of psychotomimetic drugs in mice with altered NMDA receptor function. Psychopharmacology (Berl). 2011 Jan; 213(1):143-53. PMID: 20865248.
    View in: PubMed
  49. Coyle JT, Balu D, Benneyworth M, Basu A, Roseman A. Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia. Dialogues Clin Neurosci. 2010; 12(3):359-82. PMID: 20954431; PMCID: PMC3181979.
  50. Coyle JT. MicroRNAs suggest a new mechanism for altered brain gene expression in schizophrenia. Proc Natl Acad Sci U S A. 2009 Mar 3; 106(9):2975-6. PMID: 19251669; PMCID: PMC2651256.
  51. Coyle JT. Erratum: "Prevalence, heritability, and prospective risk factors for anorexia nervosa" (2006;63[3]:305-312). Arch Gen Psychiatry. 2008 Sep; 65(9):994. PMID: 18762585.
    View in: PubMed
  52. Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S, Grace AA. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 2008 May; 31(5):234-42. PMID: 18395805; PMCID: PMC2680493.
  53. Eaton DL, Daroff RB, Autrup H, Bridges J, Buffler P, Costa LG, Coyle J, McKhann G, Mobley WC, Nadel L, Neubert D, Schulte-Hermann R, Spencer PS. Review of the toxicology of chlorpyrifos with an emphasis on human exposure and neurodevelopment. Crit Rev Toxicol. 2008; 38 Suppl 2:1-125. PMID: 18726789.
    View in: PubMed
  54. Coyle JT, Geerts H, Sorra K, Amatniek J. Beyond in vitro data: a review of in vivo evidence regarding the allosteric potentiating effect of galantamine on nicotinic acetylcholine receptors in Alzheimer's neuropathology. J Alzheimers Dis. 2007 Jul; 11(4):491-507. PMID: 17656829.
    View in: PubMed
  55. Coyle JT. Substance use disorders and Schizophrenia: a question of shared glutamatergic mechanisms. Neurotox Res. 2006 Dec; 10(3-4):221-33. PMID: 17197372.
    View in: PubMed
  56. Siekmeier PJ, Hasselmo ME, Howard MW, Coyle J. Modeling of context-dependent retrieval in hippocampal region CA1: implications for cognitive function in schizophrenia. Schizophr Res. 2007 Jan; 89(1-3):177-90. PMID: 17055702.
    View in: PubMed
  57. Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT. Neurobiology of schizophrenia. Neuron. 2006 Oct 5; 52(1):139-53. PMID: 17015232.
    View in: PubMed
  58. Coyle JT. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol. 2006 Jul-Aug; 26(4-6):365-84. PMID: 16773445.
    View in: PubMed
  59. Frye MA, Tsai GE, Huggins T, Coyle JT, Post RM. Low cerebrospinal fluid glutamate and glycine in refractory affective disorder. Biol Psychiatry. 2007 Jan 15; 61(2):162-6. PMID: 16735030.
    View in: PubMed
  60. Coyle JT. Glial metabolites of tryptophan and excitotoxicity: coming unglued. Exp Neurol. 2006 Jan; 197(1):4-7. PMID: 16300760.
    View in: PubMed
  61. Picker JD, Coyle JT. Do maternal folate and homocysteine levels play a role in neurodevelopmental processes that increase risk for schizophrenia? Harv Rev Psychiatry. 2005 Jul-Aug; 13(4):197-205. PMID: 16126606.
    View in: PubMed
  62. Yurgelun-Todd DA, Coyle JT, Gruber SA, Renshaw PF, Silveri MM, Amico E, Cohen B, Goff DC. Functional magnetic resonance imaging studies of schizophrenic patients during word production: effects of D-cycloserine. Psychiatry Res. 2005 Jan 30; 138(1):23-31. PMID: 15708298.
    View in: PubMed
  63. Martina M, B-Turcotte ME, Halman S, Tsai G, Tiberi M, Coyle JT, Bergeron R. Reduced glycine transporter type 1 expression leads to major changes in glutamatergic neurotransmission of CA1 hippocampal neurones in mice. J Physiol. 2005 Mar 15; 563(Pt 3):777-93. PMID: 15661817; PMCID: PMC1665613.
  64. Coyle JT. The GABA-glutamate connection in schizophrenia: which is the proximate cause? Biochem Pharmacol. 2004 Oct 15; 68(8):1507-14. PMID: 15451393.
    View in: PubMed
  65. Goff DC, Bottiglieri T, Arning E, Shih V, Freudenreich O, Evins AE, Henderson DC, Baer L, Coyle J. Folate, homocysteine, and negative symptoms in schizophrenia. Am J Psychiatry. 2004 Sep; 161(9):1705-8. PMID: 15337665.
    View in: PubMed
  66. Tsai G, Ralph-Williams RJ, Martina M, Bergeron R, Berger-Sweeney J, Dunham KS, Jiang Z, Caine SB, Coyle JT. Gene knockout of glycine transporter 1: characterization of the behavioral phenotype. Proc Natl Acad Sci U S A. 2004 Jun 1; 101(22):8485-90. PMID: 15159536; PMCID: PMC420420.
  67. Coyle JT, Tsai G. NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia. Int Rev Neurobiol. 2004; 59:491-515. PMID: 15006500.
    View in: PubMed
  68. Javitt DC, Coyle JT. Decoding schizophrenia. Sci Am. 2004 Jan; 290(1):48-55. PMID: 14682038.
    View in: PubMed
  69. Coyle JT, Pine DS, Charney DS, Lewis L, Nemeroff CB, Carlson GA, Joshi PT, Reiss D, Todd RD, Hellander M. Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in children and adolescents. J Am Acad Child Adolesc Psychiatry. 2003 Dec; 42(12):1494-503. PMID: 14627885.
    View in: PubMed
  70. Coyle JT, Tsai G. The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia. Psychopharmacology (Berl). 2004 Jun; 174(1):32-8. PMID: 15205876.
    View in: PubMed
  71. Coyle JT, Tsai G, Goff D. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann N Y Acad Sci. 2003 Nov; 1003:318-27. PMID: 14684455.
    View in: PubMed
  72. Coyle JT. Use it or lose it--do effortful mental activities protect against dementia? N Engl J Med. 2003 Jun 19; 348(25):2489-90. PMID: 12815133.
    View in: PubMed
  73. Coyle JT, Duman RS. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron. 2003 Apr 24; 38(2):157-60. PMID: 12718851.
    View in: PubMed
  74. Flores C, Coyle JT. Regulation of glutamate carboxypeptidase II function in corticolimbic regions of rat brain by phencyclidine, haloperidol, and clozapine. Neuropsychopharmacology. 2003 Jul; 28(7):1227-34. PMID: 12700705.
    View in: PubMed
  75. Coyle JT. A continuing commitment to excellence. Arch Gen Psychiatry. 2002 Nov; 59(11):977. PMID: 12418929.
    View in: PubMed
  76. Coyle JT, Manji HK. Getting balance: drugs for bipolar disorder share target. Nat Med. 2002 Jun; 8(6):557-8. PMID: 12042799.
    View in: PubMed
  77. Coyle JT, Tsai G, Goff DC. Ionotropic glutamate receptors as therapeutic targets in schizophrenia. Curr Drug Targets CNS Neurol Disord. 2002 Apr; 1(2):183-9. PMID: 12769626.
    View in: PubMed
  78. Tsai G, Coyle JT. Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol. 2002; 42:165-79. PMID: 11807169.
    View in: PubMed
  79. Frazier JA, Doyle R, Chiu S, Coyle JT. Treating a child with Asperger's disorder and comorbid bipolar disorder. Am J Psychiatry. 2002 Jan; 159(1):13-21. PMID: 11772683.
    View in: PubMed
  80. Leski ML, Hassinger LC, Valentine SL, Baer JD, Coyle JT. L-type calcium channels reduce ROS generation in cerebellar granule cells following kainate exposure. Synapse. 2002 Jan; 43(1):30-41. PMID: 11746731.
    View in: PubMed
  81. Goff DC, Coyle JT. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry. 2001 Sep; 158(9):1367-77. PMID: 11532718.
    View in: PubMed
  82. Coyle J, Kershaw P. Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease. Biol Psychiatry. 2001 Feb 1; 49(3):289-99. PMID: 11230880.
    View in: PubMed
  83. Leski ML, Valentine SL, Baer JD, Coyle JT. Insulin-like growth factor I prevents the development of sensitivity to kainate neurotoxicity in cerebellar granule cells. J Neurochem. 2000 Oct; 75(4):1548-56. PMID: 10987835.
    View in: PubMed
  84. Nguyen TV, Brownell AL, Iris Chen YC, Livni E, Coyle JT, Rosen BR, Cavagna F, Jenkins BG. Detection of the effects of dopamine receptor supersensitivity using pharmacological MRI and correlations with PET. Synapse. 2000 Apr; 36(1):57-65. PMID: 10700026.
    View in: PubMed
  85. Price BH, Adams RD, Coyle JT. Neurology and psychiatry: closing the great divide. Neurology. 2000 Jan 11; 54(1):8-14. PMID: 10636118.
    View in: PubMed
  86. Coyle JT, Schwarcz R. Mind glue: implications of glial cell biology for psychiatry. Arch Gen Psychiatry. 2000 Jan; 57(1):90-3. PMID: 10632240.
    View in: PubMed
  87. Berger UV, Luthi-Carter R, Passani LA, Elkabes S, Black I, Konradi C, Coyle JT. Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system. J Comp Neurol. 1999 Dec 6; 415(1):52-64. PMID: 10540357.
    View in: PubMed
  88. Lindley CR, Coyle JT. Psychopharmacologist as family doctor: complications in the joint treatment of a husband and wife. Harv Rev Psychiatry. 1999 Nov-Dec; 7(4):222-9. PMID: 10579102.
    View in: PubMed
  89. Tsai GE, Yang P, Chung LC, Tsai IC, Tsai CW, Coyle JT. D-serine added to clozapine for the treatment of schizophrenia. Am J Psychiatry. 1999 Nov; 156(11):1822-5. PMID: 10553752.
    View in: PubMed
  90. Leski ML, Valentine SL, Coyle JT. L-type voltage-gated calcium channels modulate kainic acid neurotoxicity in cerebellar granule cells. Brain Res. 1999 May 15; 828(1-2):27-40. PMID: 10320722.
    View in: PubMed
  91. Coyle JT. Ice-nine and human prion disease. Harv Rev Psychiatry. 1999 Mar-Apr; 6(6):331-3. PMID: 10370441.
    View in: PubMed
  92. Tsai GE, Falk WE, Gunther J, Coyle JT. Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment. Am J Psychiatry. 1999 Mar; 156(3):467-9. PMID: 10080566.
    View in: PubMed
  93. Goff DC, Tsai G, Levitt J, Amico E, Manoach D, Schoenfeld DA, Hayden DL, McCarley R, Coyle JT. A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry. 1999 Jan; 56(1):21-7. PMID: 9892252.
    View in: PubMed
  94. Speno HS, Luthi-Carter R, Macias WL, Valentine SL, Joshi AR, Coyle JT. Site-directed mutagenesis of predicted active site residues in glutamate carboxypeptidase II. Mol Pharmacol. 1999 Jan; 55(1):179-85. PMID: 9882712.
    View in: PubMed
  95. Tsai G, Yang P, Chung LC, Lange N, Coyle JT. D-serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry. 1998 Dec 1; 44(11):1081-9. PMID: 9836012.
    View in: PubMed
  96. Luthi-Carter R, Barczak AK, Speno H, Coyle JT. Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase). J Pharmacol Exp Ther. 1998 Aug; 286(2):1020-5. PMID: 9694964.
    View in: PubMed
  97. Schwartz PJ, Coyle JT. Effects of overexpression of the cytoplasmic copper-zinc superoxide dismutase on the survival of neurons in vitro. Synapse. 1998 Jul; 29(3):206-12. PMID: 9635890.
    View in: PubMed
  98. Steingard RJ, Schmidt C, Coyle JT. Basic neuroscience: critical issues for understanding psychiatric disorders. Adolesc Med. 1998 Jun; 9(2):205-15, v. PMID: 10961230.
    View in: PubMed
  99. Schwartz PJ, Reaume A, Scott R, Coyle JT. Effects of over- and under-expression of Cu,Zn-superoxide dismutase on the toxicity of glutamate analogs in transgenic mouse striatum. Brain Res. 1998 Apr 6; 789(1):32-9. PMID: 9602043.
    View in: PubMed
  100. Tsai G, Coyle JT. The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med. 1998; 49:173-84. PMID: 9509257.
    View in: PubMed
  101. Coyle JT, Mallet J. Disease, transplantation and regeneration. Curr Opin Neurobiol. 1997 Oct; 7(5):663-5. PMID: 9384555.
    View in: PubMed
  102. Goff DC, Tsai G, Manoach DS, Flood J, Darby DG, Coyle JT. D-cycloserine added to clozapine for patients with schizophrenia. Am J Psychiatry. 1996 Dec; 153(12):1628-30. PMID: 8942463.
    View in: PubMed
  103. Simonian NA, Getz RL, Leveque JC, Konradi C, Coyle JT. Kainate induces apoptosis in neurons. Neuroscience. 1996 Oct; 74(3):675-83. PMID: 8884764.
    View in: PubMed
  104. Didier M, Bursztajn S, Adamec E, Passani L, Nixon RA, Coyle JT, Wei JY, Berman SA. DNA strand breaks induced by sustained glutamate excitotoxicity in primary neuronal cultures. J Neurosci. 1996 Apr 1; 16(7):2238-50. PMID: 8601804.
    View in: PubMed
  105. Simonian NA, Coyle JT. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol. 1996; 36:83-106. PMID: 8725383.
    View in: PubMed
  106. Coyle JT. The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry. 1996 Jan-Feb; 3(5):241-53. PMID: 9384954.
    View in: PubMed
  107. Coyle JT. The neuroscience perspective and the changing role of the psychiatrist : the challenge for psychiatric educators. Acad Psychiatry. 1995 Dec; 19(4):202-12. PMID: 24435610.
    View in: PubMed
  108. Coyle JT. Food for thought. Nat Med. 1995 Oct; 1(10):1006-7. PMID: 7489354.
    View in: PubMed
  109. Baer L, Cukor P, Jenike MA, Leahy L, O'Laughlen J, Coyle JT. Pilot studies of telemedicine for patients with obsessive-compulsive disorder. Am J Psychiatry. 1995 Sep; 152(9):1383-5. PMID: 7653700.
    View in: PubMed
  110. Schwartz PJ, Berger UV, Coyle JT. Mice transgenic for copper/zinc superoxide dismutase exhibit increased markers of biogenic amine function. J Neurochem. 1995 Aug; 65(2):660-9. PMID: 7616222.
    View in: PubMed
  111. Tsai G, Coyle JT. N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol. 1995 Aug; 46(5):531-40. PMID: 8532851.
    View in: PubMed
  112. Goff DC, Tsai G, Manoach DS, Coyle JT. Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am J Psychiatry. 1995 Aug; 152(8):1213-5. PMID: 7625475.
    View in: PubMed
  113. Baer L, Jacobs DG, Cukor P, O'Laughlen J, Coyle JT, Magruder KM. Automated telephone screening survey for depression. JAMA. 1995 Jun 28; 273(24):1943-4. PMID: 7783305.
    View in: PubMed
  114. Tsai G, Gastfriend DR, Coyle JT. The glutamatergic basis of human alcoholism. Am J Psychiatry. 1995 Mar; 152(3):332-40. PMID: 7864257.
    View in: PubMed
  115. Berger UV, Carter RE, McKee M, Coyle JT. N-acetylated alpha-linked acidic dipeptidase is expressed by non-myelinating Schwann cells in the peripheral nervous system. J Neurocytol. 1995 Feb; 24(2):99-109. PMID: 7745446.
    View in: PubMed
  116. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 1993 Oct 29; 262(5134):689-95. PMID: 7901908.
    View in: PubMed
  117. Puttfarcken PS, Getz RL, Coyle JT. Kainic acid-induced lipid peroxidation: protection with butylated hydroxytoluene and U78517F in primary cultures of cerebellar granule cells. Brain Res. 1993 Oct 8; 624(1-2):223-32. PMID: 8252395.
    View in: PubMed
  118. Puttfarcken PS, Lyons WE, Coyle JT. Dissociation of nitric oxide generation and kainate-mediated neuronal degeneration in primary cultures of rat cerebellar granule cells. Neuropharmacology. 1992 Jun; 31(6):565-75. PMID: 1328917.
    View in: PubMed
  119. Coyle JT. Basic models of Alzheimer's disease. Clin Neuropharmacol. 1992; 15 Suppl 1 Pt A:35A. PMID: 1498867.
    View in: PubMed
  120. Schwarcz R, Bennett JP, Coyle JT. Loss of striatal serotonin synaptic receptor binding induced by kainic acid lesions: correlations with Huntington's Disease. J Neurochem. 1977 Apr; 28(4):867-9. PMID: 142820.
    View in: PubMed
  121. Bergeron R, Imamura Y, Frangioni JV, Greene RW, Coyle JT. Endogenous N-acetylaspartylglutamate reduced NMDA receptor-dependent current neurotransmission in the CA1 area of the hippocampus. J Neurochem. 2007 Jan; 100(2):346-57. PMID: 17241157.
    View in: PubMed
  122. Luthi-Carter R, Berger UV, Barczak AK, Enna M, Coyle JT. Isolation and expression of a rat brain cDNA encoding glutamate carboxypeptidase II. Proc Natl Acad Sci U S A. 1998 Mar 17; 95(6):3215-20. PMID: 9501243; PMCID: PMC19722.
  123. Benneyworth MA, Roseman AS, Basu AC, Coyle JT. Failure of NMDA receptor hypofunction to induce a pathological reduction in PV-positive GABAergic cell markers. Neurosci Lett. 2011 Jan 25; 488(3):267-71. PMID: 21094213; PMCID: PMC3025532.
  124. Tsai G, Cork LC, Slusher BS, Price D, Coyle JT. Abnormal acidic amino acids and N-acetylaspartylglutamate in hereditary canine motoneuron disease. Brain Res. 1993 Dec 3; 629(2):305-9. PMID: 8111634.
    View in: PubMed
  125. Lawson-Yuen A, Liu D, Han L, Jiang ZI, Tsai GE, Basu AC, Picker J, Feng J, Coyle JT. Ube3a mRNA and protein expression are not decreased in Mecp2R168X mutant mice. Brain Res. 2007 Nov 14; 1180:1-6. PMID: 17936729; PMCID: PMC2706140.
  126. Leveque JC, Macías W, Rajadhyaksha A, Carlson RR, Barczak A, Kang S, Li XM, Coyle JT, Huganir RL, Heckers S, Konradi C. Intracellular modulation of NMDA receptor function by antipsychotic drugs. J Neurosci. 2000 Jun 1; 20(11):4011-20. PMID: 10818136; PMCID: PMC4203343.
  127. Ghose S, Weickert CS, Colvin SM, Coyle JT, Herman MM, Hyde TM, Kleinman JE. Glutamate carboxypeptidase II gene expression in the human frontal and temporal lobe in schizophrenia. Neuropsychopharmacology. 2004 Jan; 29(1):117-25. PMID: 14560319.
    View in: PubMed
  128. DeVito LM, Balu DT, Kanter BR, Lykken C, Basu AC, Coyle JT, Eichenbaum H. Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology. Genes Brain Behav. 2011 Mar; 10(2):210-22. PMID: 21029376; PMCID: PMC3348622.
  129. Balu DT, Coyle JT. Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia. Neurosci Biobehav Rev. 2011 Jan; 35(3):848-70. PMID: 20951727; PMCID: PMC3005823.
  130. Ghose S, Chin R, Gallegos A, Roberts R, Coyle J, Tamminga C. Localization of NAAG-related gene expression deficits to the anterior hippocampus in schizophrenia. Schizophr Res. 2009 Jun; 111(1-3):131-7. PMID: 19403271; PMCID: PMC2685203.
  131. Tsai G, Dunham KS, Drager U, Grier A, Anderson C, Collura J, Coyle JT. Early embryonic death of glutamate carboxypeptidase II (NAALADase) homozygous mutants. Synapse. 2003 Dec 15; 50(4):285-92. PMID: 14556233.
    View in: PubMed
  132. Bergeron R, Coyle JT. NAAG, NMDA receptor and psychosis. Curr Med Chem. 2012; 19(9):1360-4. PMID: 22304714; PMCID: PMC3424071.
  133. Simonian NA, Getz RL, Leveque JC, Konradi C, Coyle JT. Kainic acid induces apoptosis in neurons. Neuroscience. 1996 Dec; 75(4):1047-55. PMID: 8938740.
    View in: PubMed
  134. Regenberg A, Mathews DJ, Blass DM, Bok H, Coyle JT, Duggan P, Faden R, Finkel J, Gearhart JD, Hillis A, Hoke A, Johnson R, Johnston M, Kahn J, Kerr D, King P, Kurtzberg J, Liao SM, McDonald JW, McKhann G, Nelson KB, Rao M, Siegel AW, Smith K, Solter D, Song H, Sugarman J, Vescovi A, Young W, Greely HT, Traystman RJ. The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditions. J Cereb Blood Flow Metab. 2009 Jan; 29(1):1-9. PMID: 18728679; PMCID: PMC2682696.
  135. Reed BT, Sullivan SJ, Tsai G, Coyle JT, Esguerra M, Miller RF. The glycine transporter GlyT1 controls N-methyl-D-aspartic acid receptor coagonist occupancy in the mouse retina. Eur J Neurosci. 2009 Dec; 30(12):2308-17. PMID: 20092573; PMCID: PMC2910544.
  136. Passani L, Elkabes S, Coyle JT. Evidence for the presence of N-acetylaspartylglutamate in cultured oligodendrocytes and LPS activated microglia. Brain Res. 1998 May 25; 794(1):143-5. PMID: 9630582.
    View in: PubMed
  137. Han L, Wong DL, Tsai G, Jiang Z, Coyle JT. Promoter analysis of human glutamate carboxypeptidase II. Brain Res. 2007 Sep 19; 1170:1-12. PMID: 17689503; PMCID: PMC2706136.
  138. Puttfarcken PS, Handen JS, Montgomery DT, Coyle JT, Werling LL. N-acetyl-aspartylglutamate modulation of N-methyl-D-aspartate-stimulated [3H]norepinephrine release from rat hippocampal slices. J Pharmacol Exp Ther. 1993 Aug; 266(2):796-803. PMID: 8355209.
    View in: PubMed
  139. Coyle JT. What can a clock mutation in mice tell us about bipolar disorder? Proc Natl Acad Sci U S A. 2007 Apr 10; 104(15):6097-8. PMID: 17404212; PMCID: PMC1851026.
  140. Tsai G, Slusher BS, Sim L, Coyle JT. Immunocytochemical distribution of N-acetylaspartylglutamate in the rat forebrain and glutamatergic pathways. J Chem Neuroanat. 1993 Sep-Oct; 6(5):277-92. PMID: 7903856.
    View in: PubMed
  141. Bergeron R, Meyer TM, Coyle JT, Greene RW. Modulation of N-methyl-D-aspartate receptor function by glycine transport. Proc Natl Acad Sci U S A. 1998 Dec 22; 95(26):15730-4. PMID: 9861038; PMCID: PMC28112.
  142. Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE, Coyle JT. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry. 1995 Oct; 52(10):829-36. PMID: 7575102.
    View in: PubMed
  143. Mustafa AK, Ahmad AS, Zeynalov E, Gazi SK, Sikka G, Ehmsen JT, Barrow RK, Coyle JT, Snyder SH, Doré S. Serine racemase deletion protects against cerebral ischemia and excitotoxicity. J Neurosci. 2010 Jan 27; 30(4):1413-6. PMID: 20107067; PMCID: PMC2841469.
  144. Luthi-Carter R, Barczak AK, Speno H, Coyle JT. Hydrolysis of the neuropeptide N-acetylaspartylglutamate (NAAG) by cloned human glutamate carboxypeptidase II. Brain Res. 1998 Jun 8; 795(1-2):341-8. PMID: 9622670.
    View in: PubMed
  145. Balu DT, Coyle JT. Glutamate receptor composition of the post-synaptic density is altered in genetic mouse models of NMDA receptor hypo- and hyperfunction. Brain Res. 2011 May 25; 1392:1-7. PMID: 21443867; PMCID: PMC3225000.
  146. Tsai G, Goff DC, Chang RW, Flood J, Baer L, Coyle JT. Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia. Am J Psychiatry. 1998 Sep; 155(9):1207-13. PMID: 9734544.
    View in: PubMed
  147. Han L, Picker JD, Schaevitz LR, Tsai G, Feng J, Jiang Z, Chu HC, Basu AC, Berger-Sweeney J, Coyle JT. Phenotypic characterization of mice heterozygous for a null mutation of glutamate carboxypeptidase II. Synapse. 2009 Aug; 63(8):625-35. PMID: 19347959; PMCID: PMC2749286.
  148. Carter RE, Feldman AR, Coyle JT. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc Natl Acad Sci U S A. 1996 Jan 23; 93(2):749-53. PMID: 8570628; PMCID: PMC40126.
  149. Coyle JT. A brief overview of N-acetylaspartate and N-acetylaspartylglutamate. Adv Exp Med Biol. 2006; 576:1-6; discussion 361-3. PMID: 16802701.
    View in: PubMed
  150. Tsai G, van Kammen DP, Chen S, Kelley ME, Grier A, Coyle JT. Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia. Biol Psychiatry. 1998 Oct 15; 44(8):667-74. PMID: 9798069.
    View in: PubMed
  151. Berger UV, Carter RE, Coyle JT. The immunocytochemical localization of N-acetylaspartyl glutamate, its hydrolysing enzyme NAALADase, and the NMDAR-1 receptor at a vertebrate neuromuscular junction. Neuroscience. 1995 Feb; 64(4):847-50. PMID: 7753384.
    View in: PubMed
  152. Tsai GE, Ragan P, Chang R, Chen S, Linnoila VM, Coyle JT. Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal. Am J Psychiatry. 1998 Jun; 155(6):726-32. PMID: 9619143.
    View in: PubMed
  153. Bergeron R, Coyle JT, Tsai G, Greene RW. NAAG reduces NMDA receptor current in CA1 hippocampal pyramidal neurons of acute slices and dissociated neurons. Neuropsychopharmacology. 2005 Jan; 30(1):7-16. PMID: 15354184.
    View in: PubMed
  154. Passani LA, Vonsattel JP, Carter RE, Coyle JT. N-acetylaspartylglutamate, N-acetylaspartate, and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer's diseases. Mol Chem Neuropathol. 1997 Jun; 31(2):97-118. PMID: 9376025.
    View in: PubMed
  155. Coyle JT. The nagging question of the function of N-acetylaspartylglutamate. Neurobiol Dis. 1997; 4(3-4):231-8. PMID: 9361299.
    View in: PubMed
  156. Passani LA, Vonsattel JP, Coyle JT. Distribution of N-acetylaspartylglutamate immunoreactivity in human brain and its alteration in neurodegenerative disease. Brain Res. 1997 Oct 24; 772(1-2):9-22. PMID: 9406950.
    View in: PubMed
  157. Basu AC, Tsai GE, Ma CL, Ehmsen JT, Mustafa AK, Han L, Jiang ZI, Benneyworth MA, Froimowitz MP, Lange N, Snyder SH, Bergeron R, Coyle JT. Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior. Mol Psychiatry. 2009 Jul; 14(7):719-27. PMID: 19065142; PMCID: PMC2786989.
  158. Orlando LR, Luthi-Carter R, Standaert DG, Coyle JT, Penney JB, Young AB. N-acetylaspartylglutamate (NAAG) protects against rat striatal quinolinic acid lesions in vivo. Neurosci Lett. 1997 Oct 31; 236(2):91-4. PMID: 9404819.
    View in: PubMed
  159. Santini MA, Balu DT, Puhl MD, Hill-Smith TE, Berg AR, Lucki I, Mikkelsen JD, Coyle JT. D-serine deficiency attenuates the behavioral and cellular effects induced by the hallucinogenic 5-HT(2A) receptor agonist DOI. Behav Brain Res. 2014 Feb 1; 259:242-6. PMID: 24269270; PMCID: PMC4072314.
  160. Saalau-Bethell SM, Woodhead AJ, Chessari G, Carr MG, Coyle J, Graham B, Hiscock SD, Murray CW, Pathuri P, Rich SJ, Richardson CJ, Williams PA, Jhoti H. Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function. Nat Chem Biol. 2012 Nov; 8(11):920-5. PMID: 23023261; PMCID: PMC3480716.
  161. O'Connor JE, Coyle J, Bogue C, Spence LD, Last J. Age prediction formulae from radiographic assessment of skeletal maturation at the knee in an Irish population. Forensic Sci Int. 2014 Jan; 234:188.e1-8. PMID: 24262807.
    View in: PubMed
  162. Coyle JT, Balu DT, Puhl MD, Konopaske GT. History of the Concept of Disconnectivity in Schizophrenia. Harv Rev Psychiatry. 2016 Mar-Apr; 24(2):80-6. PMID: 26954593.
    View in: PubMed
  163. Wolosker H, Balu DT, Coyle JT. The Rise and Fall of the d-Serine-Mediated Gliotransmission Hypothesis. Trends Neurosci. 2016 Nov; 39(11):712-721. PMID: 27742076.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For demographic and contact information changes only, HMS/HSDM faculty should contact Human Resources at human_resourceshms.harvard.edu.
Coyle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_